Welcome to our dedicated page for Avricore Health SEC filings (Ticker: AVCRF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to Avricore Health Inc. (OTCQB: AVCRF) SEC filings, giving investors a direct view into the company’s regulatory disclosures as a foreign private issuer. Avricore Health files under Commission File Number 000-51848 and submits reports on Form 6-K to furnish interim information to the market.
Recent Form 6-K filings include certifications of interim filings, interim financial statements, and management’s discussion and analysis (MD&A) for specific periods. For example, a Form 6-K for the month of December 2025 lists interim financial statements and an interim MD&A for a period ending September 30, 2025, along with related CEO and CFO certifications. Another Form 6-K for November 2025 includes a news release titled “HealthTab to Power NHS Pilot,” illustrating how operational updates can also appear within these submissions.
On Stock Titan, Avricore Health’s filings are complemented by AI-powered summaries that explain the key points in plain language. Long documents such as interim financial statements and MD&A are distilled so readers can quickly understand major themes, while still having access to the full original filings for detailed review.
In addition to Form 6-K reports, this page can surface other relevant SEC documents associated with AVCRF as they are filed on EDGAR. Real-time updates ensure that new submissions appear promptly, and AI-generated insights help users navigate complex financial and narrative disclosures related to Avricore Health’s pharmacy service innovation and HealthTab™ activities.
Avricore Health Inc. filed a Form 6-K as a foreign private issuer for January 2026. The filing primarily furnishes a news release titled “HealthTab to Expand Across North East London,” indicating the company is highlighting expansion activity related to its HealthTab platform in that region.
Avricore Health Inc. submitted a Form 6-K as a foreign private issuer for November 2025. The filing mainly furnishes a news release titled “HealthTab to Power NHS Pilot”, listed as Exhibit 1 and dated November 27, 2025. The report is signed on behalf of the company by Chief Financial Officer Kiki Smith on December 10, 2025, confirming the news release as official company communication.